The in vivo Pig-a gene mutation assay

Genes and Environment

Volumn 36, Issue 4, 2014, Pages 169-173

  Miura, Daishiro ^a  

^a TEIJIN LTD   (Japan)

Author keywords

Flow cytometry; Glycosylphosphatidyl inositol anchor; Phosphatidylinosital glycan anchor biosynthesis Class A gene

Indexed keywords

GLYCOSYLPHOSPHATIDYLINOSITOL;

ERYTHROCYTE; FLOW CYTOMETRY; GENE; GENE FREQUENCY; GENE MUTATION; GENOTYPE; IN VIVO STUDY; MUTAGENICITY; NONHUMAN; PHOSPHOLIPID SYNTHESIS; PIG A GENE; RETICULOCYTE; REVIEW;

BACTERIA (MICROORGANISMS); RATTUS; RODENTIA; SUIDAE;

EID: 84918840585     PISSN: 18807046     EISSN: 18807062     Source Type: Journal    
DOI: 10.3123/jemsge.2014.027     Document Type: Review

References (37)

1. Cimino MC. Comparative overview of current international strategies and guidelines for genetic toxicology testing for regulatory purposes. Environ Mol Mutagen. 2006; 47: 362-90.
2. Snyder RD, Green JW. A review of the genotoxicity of marketed pharmaceuticals. Mutat Res. 2001; 488: 151-69.
3. Kirkland D, Aardema M, Henderson L., Muller L. Evaluation of the ability of battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. Mutat Res. 2005; 584: 1-256.
4. Kawagoe K, Takeda J, Endo Y, Kinoshita T. Molecular cloning of murine Pig-a, a gene for GPI-anchor biosynthesis, and demonstration of interspecies conservation of its structure, function, and genetic locus. Genomics. 1994; 23: 566-74.
5. Watanabe R, Inoue N, Westfall B, Taron CH, Orlean P, Takeda J, et al. The first step of glycosyl-phosphatidylinositol biosynthesis is mediated by a complex of PIG-A, PIG-H, PIG-C and GPI1. EMBO J. 1998; 17: 877-85.
6. Nishimura J, Murakami Y, Kinoshita T. Paroxysmal nocturnal hemoglobinuria: An acquired genetic disease. Am J Hematol. 1999; 62: 175-82.
7. Brodsky RA, Hu R. PIG-A mutations in paroxysmal nocturnal hemoglobinuria and in normal hematopoiesis. Leuk Lymphoma. 2006; 47: 1215-21.
8. Low MG. The glycosyl-phosphatidylinositol anchor of membrane proteins. Biochim Biophys Acta. 1989; 988: 427-54.
9. Cross GA. Glycolipid anchoring of plasma membrane proteins. Annu Rev Cell Biol. 1990; 6: 1-39.
10. Hu R, Mukhina GL, Lee SH, Jones RJ, Englund PT, Brown P, et al. Silencing of genes required for glycosyl-phosphatidylinositol anchor biosynthesis in Burkitt lymphoma. Exp Hematol. 2009; 37: 423-34.
11. Takeda J, Miyata T, Kawagoe K, Iida Y, Endo Y, Fujita T, et al. Deficiency of the GPI anchor caused by somatic mutation of PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell. 1993; 72: 703-11.
12. Hall SE, Rosse WF. The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria. Blood. 1996; 87: 5332-40.
13. Araten DJ, Nafa K, Pakdeesuwan K, Luzzatto L. Clonal population of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individual. Proc Natl Acad Sci USA. 1999; 96: 5209-14.
14. Miura D, Dobrovolsky VN, Kasahara Y, Katsuura Y, Heflich RH. Development of an in vivo gene mutation assay using the endogenous Pig-A gene: I. Flow cytometic detection of CD59-negative peripheral red blood cells and CD48-negative spleen T-cells from the rat. Environ Mol Mutagen. 2008; 49: 614-21.
15. Bryce S, Bemis J, Dertinger S. In vivo mutation assay based on the endogenous Pig-a locus. Environ Mol Mutagen. 2008; 49: 256-64.
16. Kimoto T, Suzuki K, Kobayashi XM, Dobrovolsky VN, Heflich RH, Miura D, et al. Manifestation of Pig-a mutant bone marrow erythroids and peripheral blood erythrocytes in mice treated with N-ethyl-N-nitrosourea: direct sequencing of Pig-a cDNA from bone marrow cells negative for GPI-anchored protein expression. Mutat Res. 2011; 723: 36-42.
17. Kimoto T, Chikura S, Suzuki K, Kobayashi XM, Itano Y, Horibata K, et al. Further development of the rat Piga mutation assay: measuring rat Pig-a mutant bone marrow erythroids and a high throughput assay for mutant peripheral blood reticulocytes. Environ Mol Mutagen. 2011; 52: 774-83.
18. Miura D, Dobrovolsky VN, Mittelstaedt RA, Kasahara Y, Katsuura Y, Heflich RH. Development of an in vivo gene mutation assay using the endogenous Pig-A gene; II. Selection of Pig-A mutant rat spleen T-cells with Proaerolysin and sequencing Pig-A cDNA from the mutants. Environ Mol Mutagen. 2008; 49: 622-30.
19. Parker MW, van der Groot FG, Buckley JT. Aerolysin-the ins and outs of a model channel-forming toxin. Mol Microbiol. 1996; 19: 205-12.
20. Brodsky RA, Mukhina GL, Nelson KL, Lawrence RS, Jones RJ, Buckley JT. Resistance of paroxysmal nocturnal hemoglobinuria cells to the glycosylphospha-tidylinositol-binding toxin aerolysin. Blood. 1999; 93: 1749-56.
21. Miura D, Shaddock JG, Mittelstaedt RA, Dobrovolsky VN, Kimoto T, Kasahara Y, et al. Analysis of mutations in the Pig-a gene of spleen T-cell from N-ethyl-N-nitrosourea-treated Fisher 344 rats. Environ Mol Mutagen. 2011; 52: 419-23.
22. Phonethepswath S, Franklin D, Torous DK, Bryce SM, Bemis JC, Raja S, et al. Pig-a mutation: Kinetics in rat erythrocytes following exposure to five prototypical mutagens. Toxicol Sci. 2010; 114: 59-70.
23. 3H]DFP) method. Fundam Appl Toxicol. 1987; 9: 271-6.
24. Smith JE. Comparative biology and toxicology of the erythron. In: Bloom JC, editor. Comprehensive Toxicology, Vol. 4. Toxicology of the hematopoietic system. New York: Elsevier; 1997. p. 107-21.
25. Miura D, Dobrovolsky VN, Kimoto T, Kasahara Y, Heflich RH. Accumulation and persistence of Pig-A mutant peripheral red blood cells following treatment of rats with single and split doses of N-ethyl-N-nitrosourea. Mutat Res. 2009; 677: 86-92.
26. Thybaud V, Dean S, Nohmi T, de Boer J, Douglas GR, Glickman BW, et al. In vivo transgenic mutation assays. Mutat Res. 2003; 540: 141-51.
27. Keller P, Tremml G, Rosti V, Bessler M. X inactivation and somatic cell selection rescue female mice carrying a Piga-null mutation. Proc Natl Acad Sci USA. 1999; 96: 7479-83.
28. Rosti V. Murine models of paroxysmal nocturnal hemoglobinuria. Ann N Y Acad Sci. 2002; 963: 290-6.
29. Dertinger SD, Phonethepswath S, Weller P, Nicolette J, Murray J, Sonders P, et al. International Pig-a gene mutation assay trial: Evaluation of transferability across 14 laboratories. Environ Mol Mutagen. 2011; 52: 690-8.
30. Lynch AM, Giddings A, Custer L, Gleason C, Henwood A, Aylott M, et al. International Pig-a gene mutation assay trial (Stage III): Results with N-methyl-N-nitrosourea. Environ Mol Mutagen. 2011; 52: 699-710.
31. Shi J, Krsmanovic L, Bruce S, Kelly T, Paranjpe M, Szabo K, et al. Assessment of genotoxicity induced by 7,12-dimethylbenz(a)anthracene or diethylnitrosamine in the Pig-a, micronucleus and Comet assays integrated in 28-day repeat dose studies. Environ Mol Mutagen. 2011; 52: 711-20.
32. Cammerer Z, Bhalli JA, Cao X, Coffing SL, Dickinson D, Dobo KL, et al. Report on Stage III Pig-a mutation assays using N-ethyl-N-nitrosourea-Comparison with other in vivo genotoxicity endpoints, Environ Mol Mutagen. 2011; 52: 721-30.
33. Bhalli JA, Shaddock JG, Pearce MG, Dobrovolsky VN, Cao X, Heflich RH, et al. Report on Stage III Pig-a mutation assays using benzo[a]pyrene. Environ Mol Mutagen. 2011; 52: 731-7.
34. Stankowski Jr. LF, Roberts DJ, Chen H, Lawlor T, McKeon M, Murli H, et al. Integration of Pig-a, micronucleus, chromosome aberration, and Comet assay endpoints in a 28-day rodent toxicity study with 4-nitro-quinoline-1-oxide. Environ Mol Mutagen. 2011; 52: 738-47.
35. Dertinger SD, Phonethepswath S, Weller P, Avlasevich S, Torous DK, Mereness JA, et al. Interlaboratory Pig-a gene mutation assay trial: Studies of 1,3-propane sultone with immunomagnetic enrichment of mutant erythrocytes. Environ Mol Mutagen. 2011; 52: 748-55.
36. Kimoto T, Horibata K, Chikura S, Hashimoto K, Itoh S, Sanada H, et al. Interlaboratory trial of the rat Pig-a mutation assay using an erythroid marker HIS49 antibody. Mutat Res. 2013; 755 126-34.
37. Mittelstaedt RA, Smith BA, Heflich RH. Analysis of in vivo mutation induced by N-ethyl-N-nitrosourea in the hprt gene of rat lymphocytes. Environ Mol Mutagen. 1995; 26: 261-9.